Insider sells 31,000 shares totaling $4.76M

Johanna Mercier reported sales of restricted common stock.

Rhea-AI Filing Summary

Johanna Mercier reported sales of restricted common stock. The filing lists two completed dispositions: 28,000 shares sold on 02/17/2026 for $4,324,227.70 and 3,000 shares sold on 03/16/2026 for $432,690.00. The form also lists restricted stock entries dated 12/10/2024 (1,519 shares) and 09/10/2024 (1,481 shares) as securities to be sold.

The transactions are reported on a Form 144-style disclosure and show sales by an individual filing. The filing records trade dates and gross proceeds for each completed sale; additional timing or proceeds treatment for the restricted shares listed to be sold is not provided in the excerpt.

Insights

Insider Transactions Analyst

Reported insider sales totaling $4.76M across two transactions.

The filing shows two reported dispositions by Johanna Mercier: 28,000 shares on 02/17/2026 for $4,324,227.70 and 3,000 shares on 03/16/2026 for $432,690.00. These figures are explicit in the sales table.

Timing and method details beyond trade dates and gross proceeds are not included in the provided excerpt. Subsequent filings or broker confirmations may show net proceeds, broker details, or whether the sales were pursuant to a plan.

Key Figures

Sale on 02/17/2026: 28,000 shares Sale on 03/16/2026: 3,000 shares Restricted stock grant: 1,519 shares +2 more

5 metrics

Sale on 02/17/2026 28,000 shares sold on 02/17/2026 for $4,324,227.70

Sale on 03/16/2026 3,000 shares sold on 03/16/2026 for $432,690.00

Restricted stock grant 1,519 shares Restricted Stock dated 12/10/2024 listed as to be sold

Restricted stock grant 1,481 shares Restricted Stock dated 09/10/2024 listed as to be sold

Aggregate gross proceeds (reported) $4,756,917.70 Sum of reported gross proceeds from the two sales in the excerpt

Key Terms

Restricted Stock, Form 144, Gross proceeds

3 terms

Restricted Stock financial

"Restricted Stock | Issuer | 1,519 | 12/10/2024"

Shares granted to an individual that carry limits on transfer or sale until certain conditions are met, such as staying with the company for a set time or hitting performance targets. Think of them as a locked gift that gradually opens; for investors they matter because they affect how many shares may enter the market later, signal management incentives and potential dilution, and reveal confidence in future company performance.

Form 144 regulatory

"Securities Sold During The Past 3 Months"

Form 144 is a document that investors must file with the government when they plan to sell a large number of shares of a company's stock. It helps ensure transparency so everyone knows how many shares are being sold and when, which can impact the stock's price.

Gross proceeds financial

"03/16/2026 | 3,000 | 432690.00"

The total amount of cash a company receives from a financing event or sale before any fees, expenses, taxes or deductions are taken out. Investors watch gross proceeds because it shows the raw scale of new capital being raised—think of it as the paycheck amount before withholdings—which helps assess how much funding is available for operations, growth, debt payoff or how much shareholder dilution might occur once costs are removed.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What did Johanna Mercier sell according to the Form 144 (GILD)?

She sold common stock: 28,000 shares on 02/17/2026 for $4,324,227.70 and 3,000 shares on 03/16/2026 for $432,690.00. The filing lists these two trade dates and gross proceeds.

Does the filing list shares planned for sale by Johanna Mercier (GILD)?

Yes. The filing lists restricted stock dated 12/10/2024 (1,519 shares) and 09/10/2024 (1,481 shares) under "Securities To Be Sold." It identifies the security type as Restricted Stock.

Are the proceeds or broker details disclosed for these sales (GILD)?

The excerpt provides gross proceeds for each completed sale but does not show broker names or net proceeds. The sales table lists gross values only: $4,324,227.70 and $432,690.00.

What dates are associated with the reported transactions in the Form 144 (GILD)?

Completed sales have trade dates of 02/17/2026 and 03/16/2026. The securities-to-be-sold entries carry grant/issuance dates of 09/10/2024 and 12/10/2024 in the excerpt.

Does the filing indicate whether the restricted shares were issuer-granted (GILD)?

Yes. The securities listed as restricted stock are marked with the Issuer designation in the table, indicating the shares originated from the issuer under the terms shown in the excerpt.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 04/15/2026 - 04:12 PM Learn about SEC filing dates

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK	0001782135
Filer CCC	XXXXXXXX
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer	GILEAD SCIENCES, INC.
SEC File Number	000-19731
Address of Issuer	333 Lakeside Drive Foster City CALIFORNIA 94404
Phone	(650) 574-3000
Name of Person for Whose Account the Securities are To Be Sold	JOHANNA MERCIER
See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.
Relationship to Issuer	Officer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Morgan Stanley Smith Barney LLC Executive Financial Services 1 New York Plaza 8th Floor New York NY 10004	3000	422880.00	1241420528	04/15/2026	NASDAQ

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	12/10/2024	Restricted Stock	Issuer			1519	12/10/2024	Not Applicable
Common	09/10/2024	Restricted Stock	Issuer			1481	09/10/2024	Not Applicable

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
JOHANNA MERCIER 333 Lakeside Drive Foster City CA 94404	Common	03/16/2026	3000	432690.00
JOHANNA MERCIER 333 Lakeside Drive Foster City CA 94404	Common	02/17/2026	28000	4324227.70

144: Remarks and Signature

Remarks
Date of Notice	04/15/2026
Date of Plan Adoption or Giving of Instruction, If Relying on Rule 10b5-1	02/20/2025
ATTENTION:
The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.
Signature	/s/ Johanna Mercier
ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)